Top 10 Evidence-Based Essentials in Dermatology
-
By
-
Conexiant News Staff
-
April 24, 2026
-
3 min
By
Conexiant News Staff
April 24, 2026
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production
May 12, 2026
Randomized trial suggests sustained clearance across darker skin tones.
May 14, 2026